Caspofungin – The First Antifungal Drug of the Echinocandins Group

Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(1):32-34

Section
ABC of New Antimicrobials
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(1):32-34
  • 1. Hoffman H.L., Pfaller M.A.In vitrosusceptibility testing.Pharmacotherapy 2001;21:111S-23S.
  • 2. Perea S., Patterson T.F. Antifungal resistance in patho-genic fungi. Clin Infect Dis 2002;35:1073-80.
  • 3. Walsh T.J. Echinocandins – an advance in the primarytreatment of invasive candidiasis. N Engl J Med2002;347:2070-2.
  • 4. Denning D.W. Echinocandins: a new class of antifungal.J Antimicrob Chemother 2002;49:889-91.
  • 5. Rybowicz J., Gurk-Turner C. Caspofungin: the first agentavailable in the echinocandin class of antifungals. BUMCProceedings 2002;15:97-9.
  • 6. Pacetti S.A., Gelone S.P. Caspofungin acetate for treat-ment of invasive fungal infections. Ann Pharmacother2003;37:90-8.
  • 7. Walsh T.J., Adamson P.C., Seibel N.L. Pharmacokineticsof caspofungin in pediatric patients. Proceedings of 42thICAAC; 2002 Sep 27–30; San Diego, USA. M-896.
  • 8. Cancidas (caspofungin acetate) leaflet. Merk & Co.,Inc. Available from: http://www.cancidas.com.
  • 9. Hoang A. Caspofungin acetate: an antifungal agent. Am JHealth Syst Pharm 2001;58:1206-14.
  • 10. Maertens J., Raad I., Petrikkos G., et al. Update of themulticenter, noncomparative study of caspofungin inadults with invasive aspergillosis refractory or intolerantto other antifungal agents: analysis of 90 patients. 42thICAAC, San Diego; 2002. Abstract M-868.
  • 11. Mora-Duarte J., Betts R., Rotstein C., et al. Comparisonof caspofungin and amphotericin B for invasive candidia-sis. N Engl J Med 2002;374:2020-9.
  • 12. Villanueva A., Arathoon E.G., Gotuzzo E., et al. A ran-domized double-blind study of caspofungin versusamphotericin for the treatment of candidal esophagitis.Clin Infect Dis 2001;33:1529-35.
  • 13. Walsh T.J., Adamson P.C., Seibel N.L. Pharmacokineticsof caspofungin in pediatric patients. Proceedings of 42thICAAC; 2002 Sep 27–30; San Diego, USA. M-896.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared